评估实施新的人工智能分类工具的风险——在一个已经充满风险的世界里,多大的风险是合理的?

IF 1.3 Q3 ETHICS
Alexa Nord-Bronzyk, Julian Savulescu, Angela Ballantyne, Annette Braunack-Mayer, Pavitra Krishnaswamy, Tamra Lysaght, Marcus E. H. Ong, Nan Liu, Jerry Menikoff, Mayli Mertens, Michael Dunn
{"title":"评估实施新的人工智能分类工具的风险——在一个已经充满风险的世界里,多大的风险是合理的?","authors":"Alexa Nord-Bronzyk,&nbsp;Julian Savulescu,&nbsp;Angela Ballantyne,&nbsp;Annette Braunack-Mayer,&nbsp;Pavitra Krishnaswamy,&nbsp;Tamra Lysaght,&nbsp;Marcus E. H. Ong,&nbsp;Nan Liu,&nbsp;Jerry Menikoff,&nbsp;Mayli Mertens,&nbsp;Michael Dunn","doi":"10.1007/s41649-024-00348-8","DOIUrl":null,"url":null,"abstract":"<div><p>Risk prediction in emergency medicine (EM) holds unique challenges due to issues surrounding urgency, blurry research-practise distinctions, and the high-pressure environment in emergency departments (ED). Artificial intelligence (AI) risk prediction tools have been developed with the aim of streamlining triaging processes and mitigating perennial issues affecting EDs globally, such as overcrowding and delays. The implementation of these tools is complicated by the potential risks associated with over-triage and under-triage, untraceable false positives, as well as the potential for the biases of healthcare professionals toward technology leading to the incorrect usage of such tools. This paper explores risk surrounding these issues in an analysis of a case study involving a machine learning triage tool called the Score for Emergency Risk Prediction (SERP) in Singapore. This tool is used for estimating mortality risk in presentation at the ED. After two successful retrospective studies demonstrating SERP’s strong predictive accuracy, researchers decided that the pre-implementation randomised controlled trial (RCT) would not be feasible due to how the tool interacts with clinical judgement, complicating the blinded arm of the trial. This led them to consider other methods of testing SERP’s real-world capabilities, such as ongoing-evaluation type studies. We discuss the outcomes of a risk–benefit analysis to argue that the proposed implementation strategy is ethically appropriate and aligns with improvement-focused and systemic approaches to implementation, especially the learning health systems framework (LHS) to ensure safety, efficacy, and ongoing learning.</p></div>","PeriodicalId":44520,"journal":{"name":"Asian Bioethics Review","volume":"17 1","pages":"187 - 205"},"PeriodicalIF":1.3000,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11785855/pdf/","citationCount":"0","resultStr":"{\"title\":\"Assessing Risk in Implementing New Artificial Intelligence Triage Tools—How Much Risk is Reasonable in an Already Risky World?\",\"authors\":\"Alexa Nord-Bronzyk,&nbsp;Julian Savulescu,&nbsp;Angela Ballantyne,&nbsp;Annette Braunack-Mayer,&nbsp;Pavitra Krishnaswamy,&nbsp;Tamra Lysaght,&nbsp;Marcus E. H. Ong,&nbsp;Nan Liu,&nbsp;Jerry Menikoff,&nbsp;Mayli Mertens,&nbsp;Michael Dunn\",\"doi\":\"10.1007/s41649-024-00348-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Risk prediction in emergency medicine (EM) holds unique challenges due to issues surrounding urgency, blurry research-practise distinctions, and the high-pressure environment in emergency departments (ED). Artificial intelligence (AI) risk prediction tools have been developed with the aim of streamlining triaging processes and mitigating perennial issues affecting EDs globally, such as overcrowding and delays. The implementation of these tools is complicated by the potential risks associated with over-triage and under-triage, untraceable false positives, as well as the potential for the biases of healthcare professionals toward technology leading to the incorrect usage of such tools. This paper explores risk surrounding these issues in an analysis of a case study involving a machine learning triage tool called the Score for Emergency Risk Prediction (SERP) in Singapore. This tool is used for estimating mortality risk in presentation at the ED. After two successful retrospective studies demonstrating SERP’s strong predictive accuracy, researchers decided that the pre-implementation randomised controlled trial (RCT) would not be feasible due to how the tool interacts with clinical judgement, complicating the blinded arm of the trial. This led them to consider other methods of testing SERP’s real-world capabilities, such as ongoing-evaluation type studies. We discuss the outcomes of a risk–benefit analysis to argue that the proposed implementation strategy is ethically appropriate and aligns with improvement-focused and systemic approaches to implementation, especially the learning health systems framework (LHS) to ensure safety, efficacy, and ongoing learning.</p></div>\",\"PeriodicalId\":44520,\"journal\":{\"name\":\"Asian Bioethics Review\",\"volume\":\"17 1\",\"pages\":\"187 - 205\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2025-01-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11785855/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Asian Bioethics Review\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://link.springer.com/article/10.1007/s41649-024-00348-8\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ETHICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Bioethics Review","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.1007/s41649-024-00348-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ETHICS","Score":null,"Total":0}
引用次数: 0

摘要

由于急诊科(ED)的紧迫性、模糊的研究实践区别和高压环境等问题,急诊医学(EM)的风险预测面临着独特的挑战。开发人工智能(AI)风险预测工具的目的是简化分诊流程,减轻影响全球急诊科的长期问题,如过度拥挤和延误。由于与过度分类和分类不足、无法追踪的误报以及医疗保健专业人员对技术的偏见可能导致错误使用此类工具相关的潜在风险,这些工具的实施变得复杂。本文通过对一个案例研究的分析,探讨了围绕这些问题的风险,该案例研究涉及新加坡一种名为紧急风险预测评分(SERP)的机器学习分类工具。该工具用于估计急诊患者的死亡率风险。在两次成功的回顾性研究证明SERP具有很强的预测准确性后,研究人员认为实施前随机对照试验(RCT)不可行,因为该工具与临床判断相互作用,使盲法试验复杂化。这导致他们考虑其他测试SERP真实世界能力的方法,比如持续评估型研究。我们讨论了一项风险-收益分析的结果,以论证拟议的实施策略在道德上是适当的,并与以改进为重点的系统实施方法相一致,特别是学习型卫生系统框架(LHS),以确保安全性、有效性和持续学习。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Assessing Risk in Implementing New Artificial Intelligence Triage Tools—How Much Risk is Reasonable in an Already Risky World?

Risk prediction in emergency medicine (EM) holds unique challenges due to issues surrounding urgency, blurry research-practise distinctions, and the high-pressure environment in emergency departments (ED). Artificial intelligence (AI) risk prediction tools have been developed with the aim of streamlining triaging processes and mitigating perennial issues affecting EDs globally, such as overcrowding and delays. The implementation of these tools is complicated by the potential risks associated with over-triage and under-triage, untraceable false positives, as well as the potential for the biases of healthcare professionals toward technology leading to the incorrect usage of such tools. This paper explores risk surrounding these issues in an analysis of a case study involving a machine learning triage tool called the Score for Emergency Risk Prediction (SERP) in Singapore. This tool is used for estimating mortality risk in presentation at the ED. After two successful retrospective studies demonstrating SERP’s strong predictive accuracy, researchers decided that the pre-implementation randomised controlled trial (RCT) would not be feasible due to how the tool interacts with clinical judgement, complicating the blinded arm of the trial. This led them to consider other methods of testing SERP’s real-world capabilities, such as ongoing-evaluation type studies. We discuss the outcomes of a risk–benefit analysis to argue that the proposed implementation strategy is ethically appropriate and aligns with improvement-focused and systemic approaches to implementation, especially the learning health systems framework (LHS) to ensure safety, efficacy, and ongoing learning.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.20
自引率
3.40%
发文量
32
期刊介绍: Asian Bioethics Review (ABR) is an international academic journal, based in Asia, providing a forum to express and exchange original ideas on all aspects of bioethics, especially those relevant to the region. Published quarterly, the journal seeks to promote collaborative research among scholars in Asia or with an interest in Asia, as well as multi-cultural and multi-disciplinary bioethical studies more generally. It will appeal to all working on bioethical issues in biomedicine, healthcare, caregiving and patient support, genetics, law and governance, health systems and policy, science studies and research. ABR provides analyses, perspectives and insights into new approaches in bioethics, recent changes in biomedical law and policy, developments in capacity building and professional training, and voices or essays from a student’s perspective. The journal includes articles, research studies, target articles, case evaluations and commentaries. It also publishes book reviews and correspondence to the editor. ABR welcomes original papers from all countries, particularly those that relate to Asia. ABR is the flagship publication of the Centre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore. The Centre for Biomedical Ethics is a collaborating centre on bioethics of the World Health Organization.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信